Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Timson

Showing results (111-120 of 145) with videos related to

Pageof 15
Sort By:
Parasitology Research|July 10, 2012
FhCaBP4: a Fasciola hepatica calcium-binding protein with EF-hand and dynein light chain domainsRebecca Orr, Ruth Kinkead, Richard Newman, et al.
Chembiochem : a European Journal of Chemical Biology|March 6, 2018
Improving the Activity and Stability of Human Galactokinase for Therapeutic and Biotechnological ApplicationsMargaret McAuley, Noel Mesa-Torres, Aisling McFall, et al.
Biochimica Et Biophysica Acta|May 23, 2012
Altered cofactor binding affects stability and activity of human UDP-galactose 4'-epimerase: implications for type III galactosemiaThomas J McCorvie, Ying Liu, Andrew Frazer, et al.
Molecular and Cellular Biochemistry|July 1, 2008
IQ motif selectivity in human IQGAP1: binding of myosin essential light chain and S100BSevvel Pathmanathan, Sarah F Elliott, Sara McSwiggen, et al.
Parasitology Research|August 3, 2010
Liver fluke β-tubulin isotype 2 binds albendazole and is thus a probable target of this drugEmma Chambers, Louise A Ryan, Elizabeth M Hoey, et al.
Microbial Biotechnology|January 23, 2013
The biology of habitat dominance; can microbes behave as weeds?Jonathan A Cray, Andrew N W Bell, Prashanth Bhaganna, et al.
Acta Crystallographica. Section F, Structural Biology Communications|August 20, 2025
Triosephosphate isomerase from Fasciola hepatica: high-resolution crystal structure as a drug targetGeorgios Kontellas, David J Studholme, Mark van der Giezen, et al.
JIMD Reports|May 12, 2021
[<sup>13</sup>C]-galactose breath test in a patient with galactokinase deficiency and spastic diparesisCan Ficicioglu, Didem Demirbas, Britt Derks, et al.
Chemical Biology & Drug Design|April 11, 2012
The molecular dynamics of Trypanosoma brucei UDP-galactose 4'-epimerase: a drug target for African sleeping sicknessAaron J Friedman, Jacob D Durrant, Levi C T Pierce, et al.
FEBS Letters|March 18, 2014
The two common polymorphic forms of human NRH-quinone oxidoreductase 2 (NQO2) have different biochemical propertiesClare F Megarity, James R E Gill, M Clare Caraher, et al.
Pageof 15

Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
Parasitology Research|July 10, 2012
FhCaBP4: a Fasciola hepatica calcium-binding protein with EF-hand and dynein light chain domainsRebecca Orr, Ruth Kinkead, Richard Newman, et al.
Chembiochem : a European Journal of Chemical Biology|March 6, 2018
Improving the Activity and Stability of Human Galactokinase for Therapeutic and Biotechnological ApplicationsMargaret McAuley, Noel Mesa-Torres, Aisling McFall, et al.
Biochimica Et Biophysica Acta|May 23, 2012
Altered cofactor binding affects stability and activity of human UDP-galactose 4'-epimerase: implications for type III galactosemiaThomas J McCorvie, Ying Liu, Andrew Frazer, et al.
Molecular and Cellular Biochemistry|July 1, 2008
IQ motif selectivity in human IQGAP1: binding of myosin essential light chain and S100BSevvel Pathmanathan, Sarah F Elliott, Sara McSwiggen, et al.
Parasitology Research|August 3, 2010
Liver fluke β-tubulin isotype 2 binds albendazole and is thus a probable target of this drugEmma Chambers, Louise A Ryan, Elizabeth M Hoey, et al.
Microbial Biotechnology|January 23, 2013
The biology of habitat dominance; can microbes behave as weeds?Jonathan A Cray, Andrew N W Bell, Prashanth Bhaganna, et al.
Acta Crystallographica. Section F, Structural Biology Communications|August 20, 2025
Triosephosphate isomerase from Fasciola hepatica: high-resolution crystal structure as a drug targetGeorgios Kontellas, David J Studholme, Mark van der Giezen, et al.
JIMD Reports|May 12, 2021
[<sup>13</sup>C]-galactose breath test in a patient with galactokinase deficiency and spastic diparesisCan Ficicioglu, Didem Demirbas, Britt Derks, et al.
Chemical Biology & Drug Design|April 11, 2012
The molecular dynamics of Trypanosoma brucei UDP-galactose 4'-epimerase: a drug target for African sleeping sicknessAaron J Friedman, Jacob D Durrant, Levi C T Pierce, et al.
FEBS Letters|March 18, 2014
The two common polymorphic forms of human NRH-quinone oxidoreductase 2 (NQO2) have different biochemical propertiesClare F Megarity, James R E Gill, M Clare Caraher, et al.
Pageof 15